Rivaroxaban for the treatment of superficial vein thrombosis, experience at King's College Hospital

被引:4
|
作者
Clapham, Rachel E. [1 ]
Speed, Victoria [1 ,2 ]
Czuprynska, Julia [1 ]
Gazes, Anna [1 ]
Guppy, Simon [1 ]
Patel, Raj K. [1 ]
Rea, Catherine [1 ]
Vadher, Bipin [1 ]
Arya, Roopen [1 ]
Roberts, Lara N. [1 ]
机构
[1] Kings Coll Hosp NHS Fdn Trust, Kings Thrombosis Ctr, Dept Haematol Med, London, England
[2] Kings Coll London, Inst Phar maceut Sci, London, England
关键词
rivaroxaban; superficial vein thrombosis; anticoagulants; factor Xa inhibitor; DIAGNOSIS;
D O I
10.1111/bjh.17757
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E3 / E6
页数:4
相关论文
共 50 条
  • [41] Rivaroxaban for the Long-term Treatment of Spontaneous Ovarian Vein Thrombosis Caused by Factor V Leiden Homozygosity
    Cook, Rhett M.
    Rondina, Matthew T.
    Horton, Devin J.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (08) : 1055 - 1060
  • [42] Rivaroxaban: A Review of Its Use in the Treatment of Deep Vein Thrombosis or Pulmonary Embolism and the Prevention of Recurrent Venous Thromboembolism
    Celeste B. Burness
    Caroline M. Perry
    Drugs, 2014, 74 : 243 - 262
  • [43] Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis
    Bamber, Luke
    Wang, Maria Y.
    Prins, Martin H.
    Ciniglio, Cathleen
    Bauersachs, Rupert
    Lensing, Anthonie W. A.
    Cano, Stefan J.
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (04) : 732 - 741
  • [44] Oral rivaroxaban for the treatment of deep vein thrombosis in outpatients: a propensity score-matched comparison with a historical inpatient population
    Schastlivtsev, Ilya, V
    Lobastov, Kirill, V
    Dubar, Emel
    Matveeva, Athena, V
    Kovalchuk, Anna, V
    Tsaplin, Sergey N.
    Laberko, Leonid A.
    INTERNATIONAL ANGIOLOGY, 2024, 43 (06) : 553 - 562
  • [45] Efficacy of traditional Chinese medicine combined with rivaroxaban in the treatment of lower extremity deep vein thrombosis: A meta-analysis
    Zheng, Dandan
    Qi, Gui
    Adu, Isaac Kumi
    Wu, Haichao
    Zhu, Mingyuan
    MEDICINE, 2022, 101 (39) : E29483
  • [46] Treatment of superficial vein thrombosis with intermediate dose of tinzaparin: A real word cohort study - The SeVEN EXTension study
    Karathanos, Christos
    Chatzis, Dimitrios
    Latzios, Panagiotis
    Papakostas, Ioannis
    Goumas, Konstantinos
    Giannoukas, Athanasios D.
    PHLEBOLOGY, 2021, 36 (06) : 423 - 431
  • [47] Surgical and pharmaceutical treatment of superficial vein thrombosis of the lower limbs: what has changed over the last 5 years?
    Papageorgopoulou, Chrysanthi
    Nikolakopoulos, Konstantinos
    Papageorgopoulou, Aspasia
    Seretis, Charalampos
    POLISH JOURNAL OF SURGERY, 2023, 95 (06) : 62 - 67
  • [48] Urgent surgery versus anticoagulation for treatment of superficial vein thrombosis in patients with varicose veins A prospective observational cohort study
    Casian, Dumitru
    Bzovii, Florin
    Culiuc, Vasile
    Gutu, Evghenii
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2022, 51 (03) : 174 - 181
  • [49] Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: A subgroup analysis of the EINSTEIN DVT and PE studies
    Wang Y.
    Wang C.
    Chen Z.
    Zhang J.
    Liu Z.
    Jin B.
    Ying K.
    Liu C.
    Shao Y.
    Jing Z.
    Meng I.L.
    Prins M.H.
    Pap T.F.
    Müller K.
    Lensing A.W.A.
    Thrombosis Journal, 11 (1)
  • [50] Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program
    Matsuo, Hiroshi
    Prins, Martin
    Lensing, Anthonie W. A.
    Fujinuma, Emi Watanabe
    Miyamoto, Yuki
    Kajikawa, Mariko
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (06) : 1057 - 1061